| 产品名称： | Streptomyces sulfonofaciens Miyadoh et al. |
|---|---|
| 商品货号： | TS144577 |
| Strain Designations： | SF-2103 |
| Application： | Produces pluracidomycin SF-2103A |
| Isolation： | Soil, Wakayama Pref., Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes (type strain) |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Meiji Seika Kaisha, Ltd. |
| U.S. Patent Number： | |
| References： | Miyadoh S, et al. Streptomyces sulfonofaciens sp. nov. Int. J. Syst. Bacteriol. 33: 321-324, 1983. Ito T, et al. A novel beta-lactamase inhibitor, SF-2103A produced by a Streptomyces. J. Antibiot. 35: 533-535, 1982. PubMed: 6980216 Niwa T, et al. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor. J. Antibiot. 39: 943-955, 1986. PubMed: 3019978 type strain type strain |
| Cross References： | Nucleotide (GenBank) : AF318042 Streptomyces sulfonofaciens 16S ribosomal RNA gene, partial sequence. Nucleotide (GenBank) : AF141676 Streptomyces sulfonofaciens isopenicillin N synthase (pcbC) gene, partial cds. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptomyces sulfonofaciens Miyadoh et al. |
|---|---|
| 商品货号： | TS144577 |
| Strain Designations： | SF-2103 |
| Application： | Produces pluracidomycin SF-2103A |
| Isolation： | Soil, Wakayama Pref., Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes (type strain) |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Meiji Seika Kaisha, Ltd. |
| U.S. Patent Number： | |
| References： | Miyadoh S, et al. Streptomyces sulfonofaciens sp. nov. Int. J. Syst. Bacteriol. 33: 321-324, 1983. Ito T, et al. A novel beta-lactamase inhibitor, SF-2103A produced by a Streptomyces. J. Antibiot. 35: 533-535, 1982. PubMed: 6980216 Niwa T, et al. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor. J. Antibiot. 39: 943-955, 1986. PubMed: 3019978 type strain type strain |
| Cross References： | Nucleotide (GenBank) : AF318042 Streptomyces sulfonofaciens 16S ribosomal RNA gene, partial sequence. Nucleotide (GenBank) : AF141676 Streptomyces sulfonofaciens isopenicillin N synthase (pcbC) gene, partial cds. |
